Newborn screening is known to be the most successful means of secondary prevention. Horst Bickel, the man who discovered the phenylketonuria (PKU) diet, pointed out at a very early stage that his ...

Synthetic biology specialist Synlogic will start phase 3 testing of a drug for rare metabolic disorder phenylketonuria (PKU) next year, after reporting solid proof-of-concept data.